Status:
COMPLETED
Modifying Young Adult Skin Cancer Risk and Protective Behaviors
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
University of Pennsylvania
ITX Corporation
Conditions:
Melanoma and Other Malignant Neoplasms of Skin
Eligibility:
All Genders
18-25 years
Phase:
NA
Brief Summary
Skin cancer is the most common cancer and can be deadly, debilitating, damaging, and disfiguring, yet is highly preventable. In 2014, the US Surgeon General made a call to action about the "major publ...
Eligibility Criteria
Inclusion
- Moderate to high risk for skin cancer
Exclusion
- Not able to speak English
- Past history of skin cancer
Key Trial Info
Start Date :
September 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
1746 Patients enrolled
Trial Details
Trial ID
NCT03313492
Start Date
September 7 2018
End Date
July 31 2020
Last Update
September 30 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States, 08903
2
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111